Kidney News and Research

RSS

An Arm and a Leg: Attack of the Medicare machines

Covering the American health care system means we tell some scary stories. This episode of "An Arm and a Leg" sounds like a real horror movie.

10 Apr 2024

High blood levels of TMAO predicts chronic kidney disease risk in future

New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time.

9 Apr 2024

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Researchers find new clues to understanding the progression of primary membranous nephropathy

No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood.

9 Apr 2024

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

study reveals that SGLT2 inhibitors consistently lower the risk of major adverse cardiovascular events by 9% across various patient groups, especially impacting cardiovascular death reduction, highlighting their broad therapeutic potential beyond diabetes management.

9 Apr 2024

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

COVID-19 shatters decades of global health progress, slashing life expectancy

Study in The Lancet reveals COVID-19 as the second leading cause of death in 2021, disrupting three decades of progress in global health and reducing life expectancy by 2.2 years from 2019 to 2021 despite previous gains.

7 Apr 2024

Study shows promise of zilebesiran injection in reducing systolic blood pressure

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology's Annual Scientific Session.

7 Apr 2024

Combining blood pressure drug with dietary-resistant starch may help stave off diabetic kidney disease

Combining a low dose of blood pressure medication with a higher intake of dietary-resistant starch might help stave off diabetic kidney disease, according to results from a new animal study.

7 Apr 2024

Heavy alcohol use linked to increased risk of Type 2 diabetes in middle-aged adults

Heavy alcohol use may increase middle-aged adults' risk of developing Type 2 diabetes, according to research to be presented this week at the American Physiology Summit in Long Beach, California.

7 Apr 2024

Hot climates worsen chronic kidney disease outcomes

Chronic kidney disease patients living in the hottest countries experienced an additional 8% drop in kidney function each year compared to those living in temperate climates, finds a new study from researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM).

5 Apr 2024

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases.

5 Apr 2024

Dietary choices are linked to higher rates of preeclampsia among Latinas

For pregnant Latinas, food choices could reduce the risk of preeclampsia, a dangerous type of high blood pressure, and a diet based on cultural food preferences, rather than on U.S. government benchmarks, is more likely to help ward off the illness, a new study shows.

5 Apr 2024

New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

5 Apr 2024

Lancet Commission predicts sharp increase in global prostate cancer cases

Cases of prostate cancer are projected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, with low- and middle-income countries (LMICs) predicted to see the highest increases in cases, according to The Lancet Commission on prostate cancer which will be launched by a presentation at the European Association of Urology Congress.

4 Apr 2024

Kidney News and Research

An Arm and a Leg: Attack of the Medicare machines

High blood levels of TMAO predicts chronic kidney disease risk in future

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Researchers find new clues to understanding the progression of primary membranous nephropathy

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

Study: Empagliflozin shows mixed results in heart attack patients

COVID-19 shatters decades of global health progress, slashing life expectancy

Study shows promise of zilebesiran injection in reducing systolic blood pressure

Combining blood pressure drug with dietary-resistant starch may help stave off diabetic kidney disease

Heavy alcohol use linked to increased risk of Type 2 diabetes in middle-aged adults

Hot climates worsen chronic kidney disease outcomes

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Dietary choices are linked to higher rates of preeclampsia among Latinas

New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

Lancet Commission predicts sharp increase in global prostate cancer cases

Gene therapy and glycoside drugs offer new hope for polycystic kidney disease treatment

Increased coronary vessel wall thickness linked to heart dysfunction in asymptomatic HIV patients

Infertile men more likely to have impaired kidney function, study says

Global life expectancy rises by 6.2 years since 1990 despite COVID-19 setbacks

Does IBD affect cancer risk?

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News